60Nd is a revolutionary technology used by bio and pharma researchers for in vitro mechanical simulation of cells and bio tissues.
60Nd has raised $2.9M in total funding. The most recent round was Grant. The last funding was announced in February 2026.
60Nd's investors include European Innovation Council.
60Nd is headquartered in Madrid, Spain.
60Nd is a revolutionary technology used by bio and pharma researchers for in vitro mechanical simulation of cells and bio tissues.
60Nd is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"60Nd — Funding & Investors." VCBacked, February 10, 2026, https://www.vcbacked.co/company/60nd. Accessed September 30, 2026.
VCBacked. (2026). 60Nd — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/60nd
{{cite web |title=60Nd — Funding & Investors |url=https://www.vcbacked.co/company/60nd |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated